L & S Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

L & S Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,500	Closed	-$750K	–	372
2020 Q3	$750K	Buy	+5,500	New	+$585K	0.1%	199

L & S Advisors's MYOK Position: Q4 2020 in Review

L & S Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 5,500 shares — an estimated $750K sold.

L & S Advisors first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $750K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

L & S Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
L & S Advisors sold 5,500 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $750K.
L & S Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
L & S Advisors's MyoKardia, Inc. Common Stock position peaked at $750K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on L & S Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.